CMV can be a significant issue for immunocompromised individuals, particularly those undergoing cancer treatment. Chemotherapy and other cancer therapies can weaken the immune system, making patients more susceptible to infections. CMV infections can lead to serious complications, including organ damage and increased mortality rates.
